Efficacy and Safety of Vildagliptin in Combination With Insulin in Patients With Type 2 Diabetes

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
Many people with type 2 diabetes cannot maintain their target blood glucose levels on a single therapy. The purpose of this study is to assess the safety and effectiveness of vildagliptin, an unapproved drug, in lowering overall blood glucose levels when added to insulin in people with type 2 diabetes who are not at target blood glucose levels on insulin alone.
Epistemonikos ID: 299c1f25c91330a2629551bc78746535a180fb21
First added on: May 04, 2024